LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...

May 14 (Reuters) - EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the studies ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

Many common conditions linked to aging develop without symptoms for years. Learn which five pose the biggest risks and the ...

Emerging opportunities in the C5 inhibitor market include advances in biosuperiors and biosimilars, targeting a range of C5-mediated diseases such as PNH and aHUS. Innovations focus on enhancing ...

Researchers have explored the effect of different exercise patterns on the risk of developing a range of age-related eye ...

Detailed price information for Belite Bio Inc ADR (BLTE-Q) from The Globe and Mail including charting and trades.